Polpharma Pharmaceutical Works

Starogard Gdanski, 
Poland
http://www.polpharmab2b.com
  • Booth: 2250

Polpharma Group is a high quality European pharma and biotech manufacturer and a reputable business partner for pharmaceutical companies worldwide. We grow our presence through B2B activities, including API custom development and manufacturing in our cGMP-compliant and FDA-approved facility, out-licensing of vertically integrated solutions from API to finished formulation, and contract manufacturing services covering a wide variety of solid and liquid forms. We are also a fully integrated, state-of-the-art biotechnology player mastering all steps of the cell culture value chain from cell line via process and product development to GMP manufacturing up to commercial scale, applying this to own biosimilars and contract-manufacturing. www.polpharma.comwww.linkedin.com/company/polpharma www.polpharmab2b.comwww.api.polpharma.pl www.linkedin.com/company/polpharma-b2b

Brands: Alendronate sodium Risedronate sodium Aripiprazole lauroxil Apremilast N/under development Baclofen Acetazolamide Sildenafil citrate Lamotrigine Vardenafil HCL/under development Etodolac Zoledronic acid


 Press Releases

  • Following an eventful 2016, Polpharma B2B global team will be present at 2017 key industry events around the globe to present the potential of B2B offer and forge long-lasting business relations.

    At Polpharma B2B systematic contact, whether remote or direct, is the essence of true business partnership. We value networking and want to reach as many clients who look for innovation, service excellence and European quality. Our offer is present in a variety of channels, but what we truly believe in, are face-to-face meetings, handshakes and confidence in the person you are doing business with.

    Eventful 2016 was marked by successful trade shows in the US, Asia and Europe, including CPhI  Worldwide – the world’s leading pharmaceutical networking event which attracted  about 36 000 visiting professionals from 153 countries and showcased Polpharma Group as its key exhibitor for the 16th time.

    We are not slowing down in 2017  - our global team will be present at key industry events around the globe, to present the potential of B2B offer and forge long-lasting relations.

    Challenge us and let us help your business grow!

    Visit us at any of the events!

    March 8-10, 2017                             CPhI ISTANBUL

    March 20-22, 2017                           DCAT WEEK

    March 28-30, 2017                           CPhI RUSSIA

    May 16-18, 2017                               CPhI NORTH AMERICA

    June 20-22, 2017                               CPhI CHINA

    September 18-20, 2017                  PHARMA CHEMOUTSOURCING 2017

    October 24-26, 2017                        CPhI WORLDWIDE

    November 28-30, 2017                   CPhI INDIA

    Check our LinkedIn profile to learn of any new appearances announced!

    To discover more about Polpharma B2B, contact us today.

     www.polpharmab2b.com

    www.api.polpharma.pl